The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke

Author： Kiphuth Ines C   Köhrmann Martin   Huttner Hagen B   Schellinger Peter D  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.8, Iss.5, 2009-09, pp. : 585-597

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low molecular weight heparins

By Aguilar O.M.   Kleiman N.S.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1091-1103

Informa Healthcare

Access to resources Recommend Favorite

Safety Profile of Different Low-Molecular Weight Heparins Used at Therapeutic Dose

By Gouin-Thibault Isabelle  

Drug Safety, Vol. 28, Iss. 4, 2005-01 ,pp. : 333-349

Adis International

Access to resources Recommend Favorite

Safety of low molecular weight heparins in the treatment of venous thromboembolism

By Bernardi Enrico   Prandoni Paolo  

Expert Opinion on Drug Safety, Vol. 2, Iss. 1, 2003-01 ,pp. : 87-94

Informa Healthcare

Access to resources Recommend Favorite

Drug treatment of ulcerative colitis: unfractionated heparin, low molecular weight heparins and beyond

By Malhotra Samir   Bhasin Deepak   Shafiq Nusrat   Pandhi Promila  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 329-334

Informa Healthcare

Access to resources Recommend Favorite

Pharmacoeconomics of low-molecular-weight heparins: limitations of studies comparing them to unfractionated heparin

By Jones Terry E   Smith Brian J   Polasek Jonathen F  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 9, 2004-09 ,pp. : 1887-1897

Informa Healthcare

Access to resources Recommend Favorite